Prospective Study
Copyright ©The Author(s) 2020.
World J Clin Cases. Apr 6, 2020; 8(7): 1232-1240
Published online Apr 6, 2020. doi: 10.12998/wjcc.v8.i7.1232
Table 1 Baseline characteristics of the patients by Patient Health Questionnaire-9 score
VariablesOverall (n = 107)PHQ-9 score < 10 (n = 88)PHQ-9 score ≥ 10 (n = 19)P value
Demographics
Age, yr56.5 ± 10.556.2 ± 10.758.1 ± 9.80.469
Male86 (80.4)71 (80.7)15 (78.9)0.863
Medical history
History of diabetes mellitus29 (27.1)23 (26.1)6 (31.6)0.628
History of hypertension44 (41.1)34 (38.6)10 (52.6)0.261
History of cerebrovascular disease12 (11.2)11 (12.5)1 (5.3)0.365
Prior PCI3 (2.8)2 (2.3)1 (5.3)0.474
Current smoking74 (69.2)61 (69.3)13 (68.4)0.939
Clinical presentation
PHQ-9 score4.9 ± 5.12.9 ± 2.614.3 ± 2.8≤ 0.001
SBP on admission, mmHg125.9 ± 23.8125.7 ± 22.4127.0 ± 30.10.823
Heart rate on admission, bpm78.9 ± 17.277.3 ± 17.186.4 ± 16.00.037
Laboratory results on admission
Troponin-I, ng/mL27.0 (8.6, 58.5)24.7 (9.0, 56.6)32.8 (3.5, 80.0)0.504
Creatinine, µmol/l70.2 ± 16.367.9 ± 14.880.8 ± 18.90.002
Albumin, g/L40.5 ± 3.340.4 ± 3.240.7 ± 4.20.789
Hemoglobin, g/L139.9 ± 22.5139.6 ± 22.8141.6 ± 21.50.723
Fasting glucose, mmol/L7.38 ± 2.927.37 ± 2.967.43 ± 2.830.936
BNP, ng/L111 (58, 239)107 (58, 232)180 (53, 473)0.293
Total cholesterol, mmol/L4.83 ± 1.134.73 ± 1.145.31 ± 0.990.041
Low-density lipoprotein, mmol/L3.07 ± 1.002.99 ± 1.003.43 ± 0.930.08
High-density lipoprotein, mmol/L0.99 ± 0.260.97 ± 0.261.07 ± 0.270.137
Triglycerides, mmol/L1.46 (0.99, 2.26)1.46 (0.99, 2.21)1.47 (0.60, 3.29)0.929
Percutaneous coronary intervention details
Door-to-balloon time, min80.0 (50.0, 120.0)81.5 (49.9, 127.8)67.3 (50.0, 103.0)0.52
Culprit vessels0.294
Right coronary artery52 (48.6)45 (51.1)7 (36.8)
Left anterior descending artery45 (42.1)34 (38.6)11 (57.9)
Left circumflex artery10 (9.3)9 (10.2)1 (5.3)
Use of intra-aortic balloon pump3 (2.8)1 (1.1)2 (10.5)0.025
Killip class I on admission95 (88.8)80 (90.9)15 (78.9)0.134
TIMI flow grade 3 post-PCI105 (98.1)86 (97.7)19 (100)0.507
Table 2 Cardiac magnetic resonance characteristics of the patients by Patient Health Questionnaire-9score
VariableOverall (n = 107)PHQ-9 score < 10 (n = 88)PHQ-9 score ≥ 10 (n = 19)P value
LVEDV, mL/m2132.7 ± 27.5132.6 ± 23.3133.4 ± 42.80.906
LVESV, mL/m269.8 ± 27.167.9 ± 22.878.5 ± 41.60.123
SV, mL/m262.7 ± 15.364.4 ± 14.754.9 ± 16.20.014
LVEF, %48.5 ± 12.349.6 ± 11.543.7 ± 14.80.059
AAR, %33.7 ± 11.732.5 ± 11.239.3 ± 12.70.023
IS, %15.40 ± 10.1213.92 ± 7.6122.24 ± 16.200.001
MVO52 (48.6)45 (51.1)7 (36.8)0.258
IMH35 (32.7)29 (33.0)6 (31.6)0.908
MSI, %55.8 ± 26.457.3 ± 24.849.2 ± 32.90.227
Table 3 Effects of Patient Health Questionnaire-9 on large infarction size in the univariate and multivariate analyses
Univariate analysis
Multivariate analysis
OR95%CIP valueOR95%CIP value
PHQ-9 as a continuous variable
PHQ-9 score, per 1 unit increase1.1911.087-1.305≤ 0.0011.2261.073-1.4010.0031
PHQ-9 as a categorical variable
PHQ-9 ≥ 104.381.520-12.6190.0064.841.122-20.8680.0341
Table 4 Correlation between Patient Health Questionnaire-9 score and myocardial injury variables measured on cardiac magnetic resonance
Correlation coefficientP value
AAR0.2780.004
IS0.39≤ 0.001
MVO0.0380.699
IMH0.0260.793
MSI-0.1520.118